SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla hits new all-time highs, fueling community debate around the stock's valuation and future prospects, especially regarding robotaxis. Discussions also cover regulatory issues, with California potentially suspending sales over self-driving claims, though implementation is delayed. Despite mixed news, optimism persists as some anticipate further gains, while others remain cautious due to the stock's high valuation.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon's stock is trending amid discussions of its potential in AI and digital advertising, despite recent volatility. Community members are highlighting news of potential investments in OpenAI and successful satellite launches for its Leo broadband internet constellation. Some traders are noting technical indicators suggesting possible oversold conditions and a potential bullish reversal.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

SLV is trending as silver prices surge to new all-time highs, fueling community excitement and discussions around potential triple-digit prices. Community members are actively debating market manipulation, supply shortages, and the impact of industrial demand on silver's value. Some are noting JPM's shift to a long position as a bullish signal, while others caution against potential pullbacks and COMEX intervention.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is trending as investors discuss the company's upcoming product showcase, including AI improvements and expanded prediction markets. Community members are weighing the potential legal battles associated with prediction markets, while others focus on technical analysis and potential price movements. Broader market factors, such as Nasdaq's potential 23-hour trading and Bitcoin's performance, also influence the conversation around $HOOD.

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending as retail investors discuss its potential in the robotics sector following its recent merger and Nasdaq debut. Community members are drawing comparisons to previous high-flying stocks, with some setting ambitious price targets. The stock's volatility and potential short squeeze are also prominent discussion points.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community anticipates a potential breakout, with many pointing to key chart formations and historical patterns suggesting a significant move upwards. Bullish investors are actively buying dips and express strong conviction in Litecoin's long-term potential, while bears question its ability to sustain gains amidst market volatility and concerns about its performance relative to other cryptocurrencies.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending as the stock has dropped significantly, sparking community debate about its valuation, debt, and future prospects within the AI infrastructure landscape. Discussions include whether the dip presents a buying opportunity or signals deeper issues, with some pointing to analyst target prices and potential for a short covering rally, while others cite concerns about profitability and insider selling. The community is closely watching for a potential rebound, especially in light of broader discussions around AI spending and data center buildouts.

B. Riley Financial, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

B. Riley Financial Inc

B. Riley Financial is trending due to the recent filing of its overdue Q2 report, which revealed a swing to profitability and a revenue increase. Community discussions revolve around the company's progress in meeting Nasdaq's compliance deadline and potential short squeeze opportunities. Investors are also considering the implications of the company's debt and ongoing regulatory matters.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending as investors digest updated revenue guidance for 2025 and 2026, with some analysts suggesting the lowered expectations are conservative. The community is actively discussing potential entry points, dividend safety, and whether the company is a turnaround play, while also debating the CEO's performance and future prospects. Some traders are taking short-term positions, while others focus on long-term value and accumulating shares.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members rally behind its vision of merging cannabis culture with cryptocurrency on the Solana blockchain. Discussions highlight Weedcoin's long-term potential, focus on community, and its connection to the broader cannabis industry and potential benefits of cannabis research. The coin is being positioned as a culture coin, like Bitcoin but way higher.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ETF Fundamental Report for IWM

Below is Validea's ETF fundamental report for iShares Russell 2000 ETF (IWM). The report looks at IWM's exposure to the major investing factors including value, quality, momentum and low volatility...

5 Momentum ETFs With More Room to Run in 2026

AI strength, solid earnings, and upbeat 2026 forecasts fuel momentum plays. These five ETFs -- GDXJ, SLV, KBE, MDYV & IWM -- may still have room to run.

Tracking the Top-Performing Russell 2000 Stocks Against the Zacks Rank

Adding to the unusually strong performance of the Russell 2000 this year, these top performers may certainly serve as stocks to add to your watchlist

Zacks Investment Ideas feature highlights: Carvana, Lennar, Bank of America, Newmont Mining and the Russell 2000 Index ETF

A widely expected Fed rate cut puts Powell's tone in focus as investors watch how Carvana and other rate-sensitive names react.

December FOMC Preview: Rate Cut Priced in but Tone is Everything

On Wednesday, the Federal Reserve will take center stage. With a rate cut widely expected, the real story will be expectations for 2026 and how the Fed balances softening employment data with ongoing economic strength.

<ul class="summary-bullets"><li>The S&amp;P 500 is only trading within a 100-point range from its all-time highs.</li><li>Retail traders have bearish retail positioning on SPY and QQQ amid skepticism over Nvidia’s chip-export approval to China.</li><li>Siegel expects a flat December performance but sees potential for healthy consolidation and rotation into smaller, rate-sensitive stocks.</li></ul>U.S. stock futures traded narrowly mixed early Tuesday, underscoring the indecision among traders as they await the Federal Reserve’s final rate decision for the year. Risk sentiment could also take a beating from President Donald Trump’s renewed tariff salvo fired at North American neighbors, Mexico and Canada, as well as India.Writing on Truth Social, Trump&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/115686410399815717">berated</a> Mexico for violating the Water Treaty and issued an ultimatum: if Mexico does not release the agreed-upon water quota, a 5% tariff will be imposed. Separately, while speaking at a White House event, the president said he was mulling fresh tariffs on agricultural products such as Indian rice and Canadian fertilizer, Bloomberg&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-12-08/trump-eyes-tariffs-over-cheap-canadian-fertilizer-indian-rice">reported.</a>Traders may also sift through a couple of economic data points and some key earnings reports as they plot their next moves.WisdomTree Senior Economist Jeremy Siegel calls for a relatively flat performance in December as the markets digest the Fed’s message and wait for clarity on tariffs and policy heading into 2026. In his weekly commentary, the economist and strategist said, “The one seasonal I do give more weight to is the short window between Christmas and New Year’s, the so-called Santa Claus rally.”The strategist said the consolidation he predicts would be healthy "if it comes with a subtle rotation — away from over-owned megacaps and toward smaller, rate-sensitive names that benefit most from the first leg of easing.”<h2 class="st-heading-2">How Futures Are Trading</h2>As of 2:40 a.m. ET on Tuesday, the Nasdaq 100 futures, S&amp;P 500, and Dow futures were marginally higher, while the Russell 2000 futures traded down 0.08%.On Stocktwits, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, remained ‘bearish’ as of early Tuesday. The message volume on the SPY and QQQ ETF streams remained at ‘normal’ and ‘high’ levels, respectively.Most observers did not view the Trump administration’s decision to allow the export of Nvidia’s H200 chips to China favorably, as they doubted China's uptake.<stembedurl>https://stocktwits.com/newsman07336/message/638555952</stembedurl>Another user stated that a Santa Claus rally, which gives the market a year-end lift, is unlikely this year.<stembedurl>https://stocktwits.com/8Inevitableoutcome/message/638552484</stembedurl><h2 class="st-heading-2">How Markets Fared Monday</h2>Stocks were in a “wait-and-watch” mode on Monday amid uncertainty surrounding the Fed decision, due Wednesday. All but the IT sector closed in the red, with communication services, consumer discretionary, material, healthcare, and utility stocks ending markedly lower. In the process, the S&amp;P 500 Index moved away from its all-time high of 6,920.34 before settling at 6,846.51.The QQQ, SPY, and&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> fell 0.19%, 0.32% and 0.39%, respectively, while the&nbsp;<a href="https://stocktwits.com/symbol/IWM">iShares Russell 2000 ETF (IWM)</a> closed marginally higher.<h2 class="st-heading-2">Key Catalysts To Watch Out For</h2>The National Federation of Independent Business (NFIB) is scheduled to release its optimism index for November at 6 a.m. ET. The index, which measures optimism among small businesses, is expected to remain unchanged at 98.2.The Bureau of Labor Statistics is set to release the results of the Job Openings and Labor Turnover (JOLTS) survey for October at 10 a.m. ET. The reading will be closely watched, as the government suspended the release of the September report due to the shutdown.Notable names reporting earnings on Tuesday are AutoZone (AZO), G-III Apparel (GIII), Sailpoint (SAIL), AeroVironment (AVAV), Casey’s General (CASY), Cracker Barrel (CBRL), and GameStop (GME).&nbsp;<h2 class="st-heading-2">How Other Markets Fared</h2>The Asian markets fell across the board as the Fed decision loomed, while Japanese stocks closed modestly higher, supported by the yen's weakness. In a major central bank decision from the region, the Reserve Bank of Australia announced a pause, in line with expectations, and hinted that further easing is unlikely.The greenback was weaker against most major currencies, except the yen. The 10-year U.S. Treasury note yield was little changed early Tuesday after rising 3.3 points to 4.172% in the previous session. Among commodities, crude oil futures fell modestly, with the WTI crude now trading below $59 level, and gold futures also eased.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/what-a-post-powell-fed-may-look-like-under-trump-favorite-kevin-hassett/cLIYqZPREm7">What A Post-Powell Federal Reserve May Look Like Under Trump Favorite Kevin Hassett</a>

Traders work on the floor of the New York Stock Exchange (NYSE) on October 01, 2025, in New York City.  

Nasdaq, S&P 500 Futures Freeze As Fresh Trump Tariff Threats On Mexico, India Collide With Fed Jitters — Strategist Warns Santa Rally Looks Unlikely

The muted action reflects a broader sense of indecision across markets, with traders weighing the central bank’s interest-rate path against the latest geopolitical and trade uncertainties.

Equity

The muted action reflects a broader sense of indecision across markets, with traders weighing the central bank’s interest-rate path against the latest geopolitical and trade uncertainties.


Why High-Income Seekers Are Turning to Autocallable ETFs

We explain how Autocallable ETFs work and who they are for.


<ul class="summary-bullets"><li>H.C. Wainwright conservatively expects approval by the middle of 2026 and sees the shares trading well into the year-end.</li><li>Capricor’s bumper rally on Wednesday helped the stock turn green for the year.</li><li>Retail sees the stock as a long-term winner following the Phase 3 results.</li></ul>Two decades after its modest beginnings and more than a decade after becoming a public company, San Diego, California-based Capricor Therapeutics made another stride toward becoming a commercial-stage company. After a failed first try, the small-cap biotech is hoping to push its experimental cell-therapy for a rare genetic muscular disorder past the finish line without any hiccups.Wall Street analysts and the investment community received the recently released late-stage trial data for the treatment candidate well. While sell-side analysts were generous with their price target hikes, signaling their excitement toward the data, investors sent the stock up by over 530% at one point in Wednesday’s session. The initial euphoria faded slightly, but didn’t die out, as<a href="https://stocktwits.com/symbol/CAPR">&nbsp;Capricor’s stock</a> had enough verve to finish the day up 371% at $29.96,&nbsp;ending at an eight-year high and marking its best day ever.<img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_2_28_48_AM_png_599beb080a.webp" alt="Screenshot 2025-12-04 at 2.28.48 AM.png">Source: Koyfin<h2 class="st-heading-2">What Fueled CAPR’s Stratospheric Rally</h2>Wednesday, before the market opened, Capricor reported positive topline results from the Phase 3 study, dubbed HOPE-3, evaluating its Duchenne Muscular Dystrophy (DMD) cell therapy candidate, Deramiocel.-The primary endpoint, measured as the performance of upper limb (PUL), was met — showing statistically and clinically meaningful treatment effects in 54% of the patients.-The key secondary endpoint of “Left Ventricular Ejection Fraction (LVEF),” a measure of heart health, was also met.&nbsp;Thus, Deramiocel was shown to produce significant skeletal and cardiac benefits, supporting its credentials as a potential “first-in-class therapy” for Duchenne cardiomyopathy, the leading cause of mortality in DMD. The trial also gave the cell therapy a clean chit for its safety and tolerability.Capricor said it would submit the detailed results from the HOPE-3 study at a future scientific meeting and for publication in a peer-reviewed journal.Earlier in July, the FDA shot down Capricor’s initial application for Deramiocel, issuing a complete response letter (CRL) — a notice that an application cannot be approved in its current form. The agency expressed wariness about the company's efficacy data at the time and sought additional data. Industry experts saw it as a signal that the new leadership at the FDA could be veering toward a cautious approach.&nbsp;&nbsp;CEO Linda Marbán said the study results, in addition to the evidence from the HOPE-2 and HOPE-2 OLE studies, would address the clinical issues in the CRL and support regulatory approval.DMD is caused by a mutation in the DMD gene that prevents the body from producing the protein dystrophin. A lack of dystrophin hits muscle fibres, leading to muscle damage and loss.&nbsp;<h2 class="st-heading-2">What’s At Stake For Capricor</h2>According to Grand View Research, the DMD drugs<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.grandviewresearch.com/industry-analysis/duchenne-muscular-dystrophy-dmd-drugs-market">&nbsp;market</a> is expected to grow at a compounded annual growth rate (CAGR) of 16.8% from 2024, reaching $9.91 billion in 2030. North America’s revenue share was at 45% in 2023. Global Data, meanwhile, has a more muted forecast, predicting a $5.2 billion market opportunity in 2033.&nbsp;<img src="https://news.stocktwits-cdn.com/Screenshot_2025_12_04_at_3_25_08_AM_png_f4173223fa.webp" alt="Screenshot 2025-12-04 at 3.25.08 AM.png">Source: Grandview ResearchThe DMD market is currently led by Sarepta, which has a gene-replacement therapy called Eteplirsen. Elevidys, a one-time single-dose gene transfer therapy, was approved in June 2023, and its label was expanded a year later to include patients ages four and older. The gene therapy generated $131.5 million in revenue for Sarepta in the third quarter.Capricor’s Deramiocel differs from Elevidys in that it is a cell therapy that administers the patient's cardiosphere-derived cells, which secrete exosomes. The latter uses a manufactured gene for delivering the micro-dysrophin gene.Sarepta also has three FDA-approved exon-skipping therapies, Exondys 51, Amondys 45 and Vyondys 53, and it is also currently working on RNA therapies.<h2 class="st-heading-2">Big Price Target Bumps</h2>Following the data, H.C. Wainwright upped the price target for Capricor's stock to $60 from $24 and kept a 'Buy' rating, the Fly reported. The firm called the data a "decisive" win. With 78% of participants having underlying cardiomyopathy, the trial results addressed FDA concerns about sample size, the firm said. It conservatively expects approval by the middle of 2026 and sees the shares trading well into the year-end.Alliance Global called the data "unequivocally and wholly positive" and removed the speculative tag from the stock. The firm hiked its price target for the stock to $48 from $16.<h2 class="st-heading-2">Retail Convinced Of Capricor Opportunity</h2>On Stocktwits, retail investors held an 'extremely bullish' stance on Capricor stock as of early Thursday. The message volume on the stream was 'extremely high as well.A majority of retail traders are sold on Capricor's long-term potential. An ongoing Stocktwits poll asking users "What's your move on $CAPR after this Phase 3 win?" found that 53% of respondents said "This is legit — CAPR becomes a long-term winner," while 18% remained on the sidelines, waiting for approval to come through. About 29% shrugged off the rally as an "overreaction."<a href="https://stocktwits.com/StocktwitsPolls/message/638043423"><img src="https://news.stocktwits-cdn.com/CAPR_Stocktwits_poll_png_bc7624531b.webp" alt="CAPR Stocktwits poll.png"></a>CAPR stock has&nbsp;soared about 117% this year, as Wednesday's bumper rally helped it recoup all its losses to that point and turn green for the year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:<a href="https://stocktwits.com/news-articles/markets/equity/core-weave-vs-nebius-ai-infra-s-breakout-duo-backed-by-nvidia-is-outrunning-big-tech/cLIXYiKRE12">&nbsp;</a><a href="https://stocktwits.com/news-articles/markets/equity/whispers-of-an-apple-deal-rebooted-intel-s-year/cLIXAvERE1L">Whispers Of An Apple Deal Rebooted Intel’s Year — Now The Market’s Asking Whether The Old Chip Giant Can Rise Again</a>

In this photo illustration, the lCapricor Therapeutics logo is seen displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire

 DMD patients may soon gain access to a therapy that not only targets muscle decline but also tackles heart complications — the leading cause of death in this rare genetic disorder.

ETFs to Benefit From Rate Cut Bets and Upbeat Forecasts

ETFs to watch as Wall Street turns upbeat, with bullish forecasts putting the S&P 500 on track for 8,000 by 2026.

BlackRock Institutional Trust Company N.A. - iShares Russell 2000 ETF

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

IWM
iShares Russell 2000 ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IWM News

IWMiShares Russell 2000 ETF